HPCM
Hunter Perkins Capital Management Portfolio holdings
AUM
$450M
1-Year Est. Return
7.3%
1 Year Est. Return
+7.3%
AUM
$420M
AUM Growth
-$8.71M
(-2%)
Holding
114
Top Buys
| 1 | +$3.84M | |
| 2 | +$1.91M | |
| 3 | +$1.67M | |
| 4 |
John B. Sanfilippo & Son
JBSS
|
+$1.6M |
| 5 |
Graphic Packaging
GPK
|
+$1.44M |
Top Sells
| 1 | +$5.41M | |
| 2 | +$4.76M | |
| 3 | +$2.96M | |
| 4 |
Casey's General Stores
CASY
|
+$2.76M |
| 5 |
Vishay Intertechnology
VSH
|
+$2.72M |
Sector Composition
| 1 | Financials | 26.79% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Technology | 11.33% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Independence Realty Trust
IRT
$3.96B
| $408K | 0.1% |
22,875
|
|
||
102
iShares Silver Trust
SLV
$24.7B
| $366K | 0.09% |
11,163
|
|
||
103
Omnicell
OMCL
$1.58B
| $275K | 0.07% |
+9,370
|
|
||
104
SPDR Gold Trust
GLD
$131B
| $213K | 0.05% |
700
|
|
||
|
PML
105
PIMCO Municipal Income Fund II
PML
$523M
| $200K | 0.05% |
26,640
|
|
||
106
Voyager Therapeutics
VYGR
$219M
| $188K | 0.04% |
60,340
|
|
||
107
Nuvation Bio
NUVB
$1.67B
| $44K | 0.01% |
22,500
|
|
||
108
Atai Beckley NV
ATAI
$1.45B
| $32K | 0.01% |
14,741
-2,500
|
|
||
109
Mersana Therapeutics
MRSN
$140M
| $3K | ﹤0.01% |
400
|
|
||
110
Bristol-Myers Squibb
BMY
$95B
| – | – |
-78,115
|
|
||
111
Walt Disney
DIS
$189B
| – | – |
-30,018
|
|
||
112
M&T Bank
MTB
$28.7B
| – | – |
-2,075
|
|
||
113
Onto Innovation
ONTO
$6.27B
| – | – |
-2,415
|
|
||
114
SPDR S&P 500 ETF Trust
SPY
$667B
| – | – |
0
|
|